227 related articles for article (PubMed ID: 36835120)
1. Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Modulation of Obstructive Sleep Apnea.
Zdravkovic M; Harrell CR; Jakovljevic V; Djonov V; Volarevic V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835120
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 May; 8(5):. PubMed ID: 31100966
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells.
Ramos P; Rubies C; Torres M; Batlle M; Farre R; Brugada J; Montserrat JM; Almendros I; Mont L
Respir Res; 2014 Apr; 15(1):54. PubMed ID: 24775918
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells reduce inflammation in a rat model of obstructive sleep apnea.
Carreras A; Almendros I; Montserrat JM; Navajas D; Farré R
Respir Physiol Neurobiol; 2010 Jul; 172(3):210-2. PubMed ID: 20594932
[TBL] [Abstract][Full Text] [Related]
6. The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration.
Harrell CR; Djonov V; Volarevic V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804369
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications.
Li P; Ou Q; Shi S; Shao C
Cell Mol Immunol; 2023 Jun; 20(6):558-569. PubMed ID: 36973490
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms Responsible for Anti-inflammatory and Immunosuppressive Effects of Mesenchymal Stem Cell-Derived Factors.
Harrell CR; Jankovic MG; Fellabaum C; Volarevic A; Djonov V; Arsenijevic A; Volarevic V
Adv Exp Med Biol; 2019; 1084():187-206. PubMed ID: 31175638
[TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus.
Zhu L; Wang S; Qu J; Hui Z; Kan C; Hou N; Sun X
Cell Reprogram; 2022 Dec; 24(6):329-342. PubMed ID: 35877064
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis: A friend or foe in mesenchymal stem cell-based immunosuppression.
Harrell CR; Volarevic V
Adv Protein Chem Struct Biol; 2021; 126():39-62. PubMed ID: 34090619
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
13. Effects of bone marrow‑derived mesenchymal stem cell transplantation on chronic obstructive pulmonary disease/obstructive sleep apnea overlap syndrome in rats.
Chen M; Huang Z; Bi H; Pan X; He J; He L; He X; Du J; Zhou K; Wang L; Wang Q; Guo X; Jin Z
Mol Med Rep; 2019 Nov; 20(5):4665-4673. PubMed ID: 31702032
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells and allergic airway inflammation; a therapeutic approach to induce immunoregulatory responses.
Gholami M; Ghorban K; Sadeghi M; Dadmanesh M; Rouzbahani NH; Dehnavi S
Int Immunopharmacol; 2023 Jul; 120():110367. PubMed ID: 37230032
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells for inflammatory airway disorders: promises and challenges.
Fan XL; Zhang Z; Ma CY; Fu QL
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610158
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.
Zaripova LN; Midgley A; Christmas SE; Beresford MW; Pain C; Baildam EM; Oldershaw RA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003230
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases.
Harrell CR; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 Dec; 8(12):. PubMed ID: 31835680
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure.
Harrell CR; Pavlovic D; Djonov V; Volarevic V
World J Gastroenterol; 2022 Jul; 28(28):3627-3636. PubMed ID: 36161038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
